SMCHD1 is a target for gene activation therapy to treat Prader-Willi syndrome
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Deleting Smchd1 after early development in vivo activated PWS genes in disease-relevant mouse tissues including hypothalamus and improved phenotypes in a PWS mouse model.
Appeared: Sunday, October 11. Science Advances. Peer-reviewed journal.